Last reviewed · How we verify

Percocet Pill

Rothman Institute Orthopaedics · Phase 3 active Small molecule

Percocet combines oxycodone (an opioid agonist) and acetaminophen to provide pain relief through central nervous system depression and peripheral analgesic effects.

Percocet combines oxycodone (an opioid agonist) and acetaminophen to provide pain relief through central nervous system depression and peripheral analgesic effects. Used for Moderate to moderately severe acute pain, Postoperative pain management.

At a glance

Generic namePercocet Pill
SponsorRothman Institute Orthopaedics
Drug classOpioid analgesic combination
TargetMu opioid receptor (primary); also delta and kappa opioid receptors
ModalitySmall molecule
Therapeutic areaPain Management
PhasePhase 3

Mechanism of action

Oxycodone binds to mu, delta, and kappa opioid receptors in the central nervous system, reducing pain perception and emotional response to pain. Acetaminophen works through inhibition of prostaglandin synthesis, providing additional analgesic and antipyretic effects. The combination provides synergistic pain relief for moderate to moderately severe pain.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: